Organ distribution of 5-fluorouracil loaded gelatine microspheres in mice

被引:0
作者
Hao, XH
Gang, C
Zou, MJ
Jin, S
Cui, FD
机构
[1] Shenyang Pharmaceut Univ, Dept Pharmaceut, Sch Pharm, Shenyang 110016, Peoples R China
[2] Jilin Univ, Changchun 130023, Peoples R China
来源
PHARMAZIE | 2004年 / 59卷 / 09期
关键词
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The aim of this study was to investigate the organ distribution characteristics of 5-fluorouracil (5-Fu) loaded crosslinked gelatine microspheres (5-Fu-MS) after intravenous (i.v.) injection compared to 5-Fu solution in mice, and to evaluate the targetability of 5-Fu-MS. The concentrations of 5-Fu in mice plasma, heart, liver, lung, kidney, spleen and brain were determined by HPLC. The parameters drug targeting index C-e, time-averaged relative drug exposure values r(e), drug targeting efficiency t(e), and drug distributed to target-tissue (%) were used to evaluate the targetability of the 5-Fu-MS delivery system. The results showed that the concentration of 5-Fu in the lung was significantly higher than after application of 5-Fu solution, and that the maximum concentration of 5-Fu, 72.8 mug (.) g organ(-1), was reached in the lung at 15 min after i.v. administration. As for 5-Fu-MS, r(e) was calculated to be 2.2, and t(e) was considerably higher than after application of 5-Fu in solution. Furthermore, the percentage of drug distributed to the lung was 2 times as high as after application in solution. Accordingly, 5-Fu-MS were capable of effectively delivering 5-Fu to the lung and possessed specific targetability towards the lung compared to 5-Fu solution.
引用
收藏
页码:709 / 712
页数:4
相关论文
共 16 条
[1]  
Chandy T, 2000, J MICROENCAPSUL, V17, P625
[2]   In vitro and in vivo evaluation of an ocular delivery system of 5-fluorouracil microspheres [J].
Chiang, CH ;
Tung, SM ;
Lu, DW ;
Yeh, MK .
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2001, 17 (06) :545-553
[3]  
Denkbas EB, 1999, J MICROENCAPSUL, V16, P741
[4]   Skin delivery of 5-fluorouracil from ultradeformable and standard liposomes in-vitro [J].
El Maghraby, GMM ;
Williams, AC ;
Barry, BW .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2001, 53 (08) :1069-1077
[5]   QUANTITATIVE-EVALUATION OF TARGETED DRUG DELIVERY SYSTEMS [J].
GUPTA, PK ;
HUNG, CT .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1989, 56 (03) :217-226
[6]  
Jing M, 1997, Zhonghua Yan Ke Za Zhi, V33, P376
[7]  
JOONDEPH BC, 1988, OPHTHALMIC SURG LAS, V19, P252
[8]   Gelatin nanoencapsulation of protein/peptide drugs using an emulsifier-free emulsion method [J].
Li, JK ;
Wang, N ;
Wu, XS .
JOURNAL OF MICROENCAPSULATION, 1998, 15 (02) :163-172
[9]   Sustained release of 5-fluorouracil from polymeric nanoparticles [J].
McCarron, PA ;
Woolfson, AD ;
Keating, SM .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2000, 52 (12) :1451-1459
[10]   PREPARATION AND EVALUATION OF CELLULOSE NANOSPHERES CONTAINING 5-FLUOROURACIL [J].
MUKHERJI, G ;
MURTHY, RSR ;
MIGLANI, BD .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1990, 65 (1-2) :1-5